Eli Lilly (LLY)

• Market cap: $1.09T
• 1 day: 0.43%
• 5 days: 1.98%
• 1 month: 3.25%
• 3 months: 23.28%
• 6 months: 17.53%
• Year to date: 12.95%
• 1 year: 90.84%
• 5 years: 363.16%
• 10 years: 1,421.17%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000